Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04681677
Title Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab (IORT)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Xoft, Inc.
Indications

gliosarcoma

glioblastoma

Therapies

Bevacizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.